CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 121 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,191 | -64.7% | 107,900 | -53.0% | 0.00% | -100.0% |
| Q2 2023 | $394,568 | -49.4% | 229,400 | -55.6% | 0.00% | -50.0% |
| Q1 2023 | $779,311 | -7.2% | 516,100 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $839,840 | +9.8% | 524,900 | -0.5% | 0.00% | 0.0% |
| Q3 2022 | $765,000 | +8.1% | 527,400 | +36.3% | 0.00% | 0.0% |
| Q2 2022 | $708,000 | -23.9% | 387,000 | +11.1% | 0.00% | 0.0% |
| Q1 2022 | $930,000 | +6.5% | 348,300 | +72.8% | 0.00% | 0.0% |
| Q4 2021 | $873,000 | -14.7% | 201,600 | +0.2% | 0.00% | -33.3% |
| Q3 2021 | $1,024,000 | -56.2% | 201,200 | -45.5% | 0.00% | -50.0% |
| Q2 2021 | $2,336,000 | -53.6% | 369,100 | -43.3% | 0.01% | -57.1% |
| Q1 2021 | $5,031,000 | +10.9% | 650,900 | -6.1% | 0.01% | +16.7% |
| Q4 2020 | $4,538,000 | +23.1% | 692,900 | +25.0% | 0.01% | +9.1% |
| Q3 2020 | $3,685,000 | -18.3% | 554,100 | +2.3% | 0.01% | -15.4% |
| Q2 2020 | $4,513,000 | +20.6% | 541,800 | +11.1% | 0.01% | -7.1% |
| Q1 2020 | $3,741,000 | -6.2% | 487,700 | +1.6% | 0.01% | +55.6% |
| Q4 2019 | $3,990,000 | +130.1% | 480,100 | +104.4% | 0.01% | +125.0% |
| Q3 2019 | $1,734,000 | -39.0% | 234,900 | -7.2% | 0.00% | -42.9% |
| Q2 2019 | $2,841,000 | +5.3% | 253,200 | +0.8% | 0.01% | 0.0% |
| Q1 2019 | $2,699,000 | -29.7% | 251,100 | -1.2% | 0.01% | -30.0% |
| Q4 2018 | $3,837,000 | -21.7% | 254,100 | -4.1% | 0.01% | -16.7% |
| Q3 2018 | $4,901,000 | -21.8% | 264,900 | -3.4% | 0.01% | -29.4% |
| Q2 2018 | $6,266,000 | +16.7% | 274,100 | +45.2% | 0.02% | +13.3% |
| Q1 2018 | $5,371,000 | +108.3% | 188,800 | +54.6% | 0.02% | +114.3% |
| Q4 2017 | $2,578,000 | +168.3% | 122,100 | +130.8% | 0.01% | +133.3% |
| Q3 2017 | $961,000 | – | 52,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |